2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Weighted Average Number Of Diluted Shares Outstanding | NA | 28.09 | NA | NA | NA | 28.01 | 4.33 | NA | NA | 3.65 | 3.64 | |
Weighted Average Number Of Shares Outstanding Basic | NA | 28.09 | NA | NA | NA | 28.01 | 4.33 | NA | NA | 3.60 | 3.60 | |
Weighted Average Number Of Share Outstanding Basic And Diluted | NA | NA | NA | 28.03 | NA | NA | 4.33 | 3.60 | NA | NA | 3.60 | |
Income Loss From Continuing Operations Per Basic Share | NA | -0.00 | -0.00 | NA | NA | -0.00 | -0.00 | NA | NA | NA | NA | |
Income Loss From Continuing Operations Per Diluted Share | NA | -0.00 | -0.00 | NA | NA | -0.00 | -0.00 | NA | NA | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 7.89 | 10.69 | 11.69 | 11.15 | 10.11 | 9.39 | 8.31 | 9.08 | 10.16 | 8.98 | 6.04 | |
Revenues | 7.89 | 10.69 | 11.69 | 11.15 | 10.11 | 9.39 | 8.31 | 9.08 | 10.16 | 8.98 | 6.04 | |
Cost Of Goods And Services Sold | 5.78 | 5.92 | 6.44 | 5.80 | 5.13 | 5.13 | 4.96 | 4.05 | 4.59 | 3.90 | 2.58 | |
Gross Profit | 2.11 | 4.77 | 5.25 | 5.35 | 4.98 | 4.26 | 3.35 | 5.03 | 5.57 | 5.09 | 3.47 | |
Operating Expenses | 16.35 | 27.72 | 11.87 | 11.19 | 9.75 | 8.15 | 5.88 | 5.85 | 4.77 | 2.94 | 2.77 | |
Research And Development Expense | 1.87 | 1.93 | 1.93 | 2.01 | 1.39 | 1.37 | 0.85 | 0.70 | 0.48 | 0.36 | 0.34 | |
General And Administrative Expense | 7.44 | 6.50 | 7.06 | 7.29 | 6.79 | 5.61 | 3.84 | 4.16 | 3.17 | 1.73 | 1.66 | |
Selling And Marketing Expense | 2.56 | 2.40 | 2.60 | 1.60 | 1.28 | 0.89 | 0.90 | 0.70 | 0.84 | 0.56 | 0.48 | |
Operating Income Loss | -14.24 | -22.95 | -6.63 | -5.84 | -4.77 | -3.89 | -2.53 | -0.83 | 0.80 | 2.15 | 0.70 | |
Interest Income Expense Net | 0.13 | 0.07 | 0.03 | -0.01 | -0.04 | -0.26 | -0.30 | 0.01 | 0.01 | 0.02 | NA | |
Allocated Share Based Compensation Expense | 1.02 | 0.97 | 0.93 | 0.79 | 0.62 | 0.44 | 0.30 | 0.18 | 0.27 | 0.03 | NA | |
Income Tax Expense Benefit | -0.80 | -0.37 | -0.40 | -0.36 | -1.19 | -0.89 | -0.58 | -0.17 | 0.23 | 0.64 | 0.21 | |
Net Income Loss | -13.29 | -22.47 | -6.20 | -5.50 | -3.65 | -3.25 | -2.25 | -0.66 | 0.58 | 1.53 | 0.51 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 152.26 | 160.27 | 182.19 | 184.08 | 166.51 | 169.16 | 172.56 | NA | 62.91 | NA | NA | |
Liabilities | 52.38 | 48.28 | 48.73 | 45.54 | 23.31 | 22.94 | 23.53 | NA | 10.51 | NA | NA | |
Liabilities And Stockholders Equity | 152.26 | 160.27 | 182.19 | 184.08 | 166.51 | 169.16 | 172.56 | NA | 62.91 | NA | NA | |
Stockholders Equity | 99.89 | 112.00 | 133.47 | 138.55 | 143.20 | 146.23 | 149.03 | 16.29 | 16.77 | 15.93 | 14.38 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 61.14 | 70.07 | 80.27 | 91.94 | 101.20 | 111.08 | 118.32 | NA | 16.41 | NA | NA | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 42.24 | 49.85 | 64.73 | 76.45 | 87.52 | 98.01 | 108.02 | 14.47 | 3.31 | NA | NA | |
Accounts Receivable Net Current | 4.26 | 5.58 | 5.81 | 5.98 | 4.67 | 4.56 | 4.06 | NA | 4.62 | NA | NA | |
Inventory Net | 12.25 | 10.32 | 7.91 | 6.43 | 5.39 | 4.40 | 3.88 | NA | 3.58 | NA | NA | |
Inventory Finished Goods | 8.37 | 6.65 | 5.00 | 3.89 | 3.17 | 2.77 | 2.56 | NA | 2.09 | NA | NA | |
Prepaid Expense And Other Assets Current | 2.37 | 3.52 | 1.70 | 1.89 | 2.44 | 2.91 | 0.72 | NA | 1.67 | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Gross | 32.38 | 16.03 | 15.08 | 14.26 | 13.47 | 12.09 | 11.61 | NA | 8.97 | NA | NA | |
Construction In Progress Gross | 23.71 | 41.11 | 35.59 | 25.74 | 18.82 | 12.54 | 8.43 | NA | 2.03 | NA | NA | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 4.52 | 4.51 | 3.41 | 2.94 | 2.47 | 2.17 | 1.71 | NA | 0.99 | NA | NA | |
Property Plant And Equipment Net | 51.58 | 52.63 | 47.26 | 37.06 | 29.81 | 22.45 | 18.33 | NA | 10.01 | NA | NA | |
Intangible Assets Net Excluding Goodwill | 17.56 | 17.84 | 18.13 | 18.42 | 18.70 | 18.99 | 19.28 | NA | 19.85 | NA | NA | |
Finite Lived Intangible Assets Net | 4.64 | 4.92 | 5.21 | 5.50 | 5.79 | 6.07 | 6.36 | NA | NA | NA | NA | |
Intangible Assets Net Including Goodwill | 17.56 | 17.84 | 18.13 | 18.42 | 18.70 | 18.99 | 19.28 | NA | 19.85 | NA | NA | |
Other Assets Noncurrent | 2.25 | 1.18 | 0.77 | 0.40 | 0.18 | 0.03 | 0.03 | NA | 0.02 | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 10.88 | 12.33 | 11.87 | 12.64 | 7.74 | 6.20 | 5.94 | NA | 3.96 | NA | NA | |
Accounts Payable Current | 2.45 | 3.48 | 1.42 | 3.03 | 2.25 | 3.32 | 2.64 | NA | 1.64 | NA | NA | |
Other Accrued Liabilities Current | 1.24 | 1.15 | 1.36 | 1.33 | 1.23 | 0.81 | 1.43 | NA | 0.84 | NA | NA | |
Accrued Liabilities Current | 6.20 | 6.59 | 8.25 | 7.51 | 5.50 | 2.88 | 3.30 | NA | 2.33 | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt | 21.98 | 16.88 | 16.82 | 11.92 | 11.87 | 11.83 | 11.78 | NA | NA | NA | NA | |
Deferred Income Tax Liabilities Net | 1.22 | 2.03 | 2.40 | 2.79 | 3.15 | 4.35 | 5.24 | NA | 5.99 | NA | NA | |
Operating Lease Liability Noncurrent | 18.11 | 16.83 | 17.41 | 17.94 | NA | NA | NA | NA | NA | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity | 99.89 | 112.00 | 133.47 | 138.55 | 143.20 | 146.23 | 149.03 | 16.29 | 16.77 | 15.93 | 14.38 | |
Additional Paid In Capital | 154.89 | 153.71 | 152.71 | 151.58 | 150.74 | 150.12 | 149.68 | NA | 14.49 | NA | NA | |
Retained Earnings Accumulated Deficit | -55.01 | -41.71 | -19.24 | -13.04 | -7.54 | -3.89 | -0.64 | NA | 2.27 | NA | NA | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1.02 | 0.97 | 0.93 | 0.79 | 0.62 | 0.44 | 0.30 | 0.18 | 0.27 | 0.03 | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -8.03 | -8.33 | -5.84 | -5.20 | -3.08 | -7.14 | -1.25 | 2.40 | 2.43 | 1.77 | NA | |
Net Cash Provided By Used In Investing Activities | -4.73 | -6.58 | -10.92 | -5.92 | -7.41 | -3.91 | -4.67 | -1.53 | -2.66 | -0.18 | NA | |
Net Cash Provided By Used In Financing Activities | 5.14 | 0.04 | 5.04 | 0.06 | -0.00 | -1.26 | 101.78 | 10.28 | 0.00 | -1.55 | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -8.03 | -8.33 | -5.84 | -5.20 | -3.08 | -7.14 | -1.25 | 2.40 | 2.43 | 1.77 | NA | |
Net Income Loss | -13.29 | -22.47 | -6.20 | -5.50 | -3.65 | -3.25 | -2.25 | -0.66 | 0.58 | 1.53 | 0.51 | |
Depreciation Depletion And Amortization | 0.89 | 0.73 | 0.79 | 0.75 | 0.78 | 0.75 | 0.70 | 0.65 | 0.57 | 0.54 | NA | |
Increase Decrease In Accounts Receivable | -1.33 | -0.23 | -0.14 | 1.32 | 0.11 | 0.50 | -0.73 | 0.40 | -0.12 | 1.93 | NA | |
Increase Decrease In Inventories | 2.44 | 2.60 | 1.48 | 1.03 | 0.76 | 0.50 | 1.29 | -0.29 | 0.63 | -0.17 | NA | |
Increase Decrease In Accounts Payable | -0.40 | 1.25 | -0.52 | 0.24 | -0.20 | 0.50 | -1.32 | 1.28 | NA | NA | NA | |
Share Based Compensation | 1.02 | 0.97 | 0.93 | 0.79 | 0.62 | 0.44 | 0.30 | 0.18 | 0.27 | NA | NA | |
Amortization Of Financing Costs | 0.12 | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | NA | NA | NA | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | -4.73 | -6.58 | -10.92 | -5.92 | -7.41 | -3.91 | -4.67 | -1.53 | -2.66 | -0.18 | NA | |
Payments To Acquire Property Plant And Equipment | 4.73 | 6.58 | 10.92 | 5.92 | 7.41 | 3.91 | 4.67 | 3.88 | 3.50 | 1.02 | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | 5.14 | 0.04 | 5.04 | 0.06 | -0.00 | -1.26 | 101.78 | 10.28 | 0.00 | -1.55 | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 7.89 | 10.69 | 11.69 | 11.15 | 10.11 | 9.39 | 8.31 | 9.08 | 10.16 | 8.98 | 6.04 | |
Clinical Solutions | 0.77 | 0.92 | 2.94 | 3.81 | 2.44 | 1.69 | 1.59 | 1.07 | 1.67 | 1.35 | 1.21 | |
Lab Essentials | 6.93 | 9.47 | 8.39 | 6.97 | 6.74 | 7.20 | 6.46 | 6.79 | 5.75 | 5.82 | 4.43 | |
Other Product | 0.18 | 0.30 | 0.35 | 0.35 | 0.43 | 0.43 | 0.23 | 0.29 | 0.21 | 0.22 | 0.23 | |
Sample Transport | 0.00 | 0.00 | 0.00 | 0.01 | 0.49 | 0.07 | 0.04 | 0.92 | 2.53 | 1.59 | 0.17 | |
US | 7.61 | 10.38 | 11.29 | 10.82 | 9.92 | 9.11 | 8.06 | 8.71 | 9.84 | 8.75 | 5.74 | |
Non Us | 0.28 | 0.31 | 0.41 | 0.33 | 0.19 | 0.28 | 0.25 | 0.36 | 0.32 | 0.24 | 0.31 | |
Revenue From Contract With Customer Excluding Assessed Tax | 7.89 | 10.69 | 11.69 | 11.15 | 10.11 | 9.39 | 8.31 | 9.08 | 10.16 | 8.98 | 6.04 | |
Clinical Solutions | 0.77 | 0.92 | 2.94 | 3.81 | 2.44 | 1.69 | 1.59 | 1.07 | 1.67 | 1.35 | 1.21 | |
Lab Essentials | 6.93 | 9.47 | 8.39 | 6.97 | 6.74 | 7.20 | 6.46 | 6.79 | 5.75 | 5.82 | 4.43 | |
Other Product | 0.18 | 0.30 | 0.35 | 0.35 | 0.43 | 0.43 | 0.23 | 0.29 | 0.21 | 0.22 | 0.23 | |
Sample Transport | 0.00 | 0.00 | 0.00 | 0.01 | 0.49 | 0.07 | 0.04 | 0.92 | 2.53 | 1.59 | 0.17 | |
US | 7.61 | 10.38 | 11.29 | 10.82 | 9.92 | 9.11 | 8.06 | 8.71 | 9.84 | 8.75 | 5.74 | |
Non Us | 0.28 | 0.31 | 0.41 | 0.33 | 0.19 | 0.28 | 0.25 | 0.36 | 0.32 | 0.24 | 0.31 |